|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: estradiol
Summary for Generic Name: estradiol
| |||||||||||||||
Clinical Trials for: estradiolSerum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen Status: Active, not recruiting Condition: Atrophic Vaginitis; Breast Cancer Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function Status: Completed Condition: Cardiovascular Diseases Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms Status: Completed Condition: Hot Flashes Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 Mcg and Vagifem® 10 Mcg and Compare to Placebo Status: Completed Condition: Atrophic Vaginitis Due to Menopause Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions Status: Completed Condition: Healthy Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms Status: Completed Condition: Hot Flashes; Menopause; Vasomotor Disturbance Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions Status: Completed Condition: Healthy Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives. Status: Recruiting Condition: Menstrual Migraines; Menstrual Bleeding; Menstrual Spotting Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions Status: Completed Condition: Healthy Efficacy and Safety Of Spil's Estradiol Vaginal Tablet Status: Recruiting Condition: Vulvar Atrophy; Vaginal Atrophy Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Womens | PREFEST | estradiol; norgestimate | TABLET; ORAL | 021040 | Oct 22, 1999 | RX | Yes | 7,320,970 | Y | <disabled> | PREFEST IS INDICATED IN WOMEN WHO HAVE A UTERUS FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE; TREATMENT OF VULVAR AND VAGINAL ATROPHY; PREVENTION OF OSTEOPOROSIS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teva Womens | PREFEST | estradiol; norgestimate | TABLET; ORAL | 021040 | Oct 22, 1999 | RX | Yes | 6,747,019 | <disabled> | HORMONE REPLACEMENT | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Barr | ESTRADIOL AND NORGESTIMATE | estradiol; norgestimate | TABLET; ORAL | 076812 | Apr 29, 2005 | RX | No | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teva Pharms Usa | ESTRADIOL AND NORETHINDRONE ACETATE | estradiol; norethindrone acetate | TABLET; ORAL | 200747 | Mar 8, 2012 | RX | No | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc